Thyroid nodule and differentiated thyroid cancer
DOI:
https://doi.org/10.31837/relatos/6Keywords:
nódulo tiroideo, epidemiología, diagnóstico, clasificación, tiroides, cáncer diferenciado de tiroides, microcarcinoma, bocio multinodular, tratamiento quirúrgico, tratamiento médicoAbstract
It is difficult to establish a precise definition of a thyroid nodule (TN) since it does not constitute a specific nosological or anatomopathological entity, to the extent that practically any thyroid disease can present in the form of one or more TNs. Assuming that the normal anatomy of the thyroid gland is that of a homogeneous parenchyma, the thyroid nodule can be defined as an "abnormal" and focal anatomical structure, usually round or oval, single or multiple, located in the thyroid gland. The name "thyroid nodule" is therefore necessarily a provisional name until a definitive anatomic-pathological confirmation of the nature of the lesion is obtained. Furthermore, considering the way in which TN is usually diagnosed can be classified as a kind of “temporary clinical-imaging entity” (1,2). The presentation of TNs can be very varied, ranging from the single nodule to no Incidentally discovered palpable by imaging or “incidentaloma”, moving to the palpable single nodule, to the multiple non-palpable and palpable nodules and finally in ascending progression in terms of the number of nodules to the truly multinodular thyroid glands. The extensive and bilateral involvement by nodules may or may not configure a diagnosis of Multinodular Goiter, which will depend fundamentally on the total glandular volume and the presence or absence of autonomy growth in nodules (1)
Downloads
References
Pitoia F, Califano I, Vázquez A, et al. Consenso intersocietario sobre tratamiento y seguimiento de pacientes con cáncer diferenciado de tiroides. RAEM 2014, 51:85.
Gharib H, Papini E, Paschke R, et al. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 2010; 16:1.
Pacini F, Castagna M, Brilli L, et al. Thyroid Cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann of Oncol 2012; 23:111.
Cooper D, Doherty G, Haugen B, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19:1167.
Rosário P, Ward L, Carvalho G, et al. Thyroid nodules and differentiated thyroid cancer: update on the Brazilian consensus. Arq Bras Endocrinol Metab 2013; 57:240.
Camargo R, Corigliano S, Friguglietti C, et al. Latin American Thyroid Society recommendations for the
management of thyroid nodules. Arq Bras Endocrinol Metab 2009; 53:116.
Russ G, Royer B, Bigorgne C, et al. Prospective evaluation of thyroid imaging reporting and data system (TIRADS) on 4550 nodules with and without elastography. Eur J Endocrinol 2013; 168:649.
Rosario PW, Purisch S. Ultrasonographic characteristics as a criterion for repeat cytology in benign thyroid nodules. Arq Bras Endocrinol Metabol. 2010;54:52-5.
Maia F, Matos P, Pavin E, et al. Value of repeat ultrasound-guided fine-needle aspiration in thyroid nodule with a first benign cytologic result: impact of ultrasound to predict malignancy. Endocrine 2011; 40:290.
Kwak J, Kim E. Ultrasound elastography for thyroid nodules: recent advances. Ultrasonography 2014; 33:75.
Cibas E, Alis S. The Bethesda System for reporting thyroid cytopathology. Thyroid 2009; 19:1159.
Nardi F, Basolo F, Crescenzi A, et al. Italian consensus for the classification and reporting of thyroid cytology. J Endocrinol Invest 2014; 37:593.
Kakudo K, Kameyama K, Miyauchi A, et al. Introducing the reporting system for thyroid fine-needle aspiration cytology according to the new guidelines of the Japan Thyroid Association. Endocrine Journal 2014; 61:539.
Matos P, Ferreira A, Facuri F, et al. Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy. Histopathology 2005; 47:391.102
Saleh HA, Feng J, Tabassum F, et al. Differential expression of galectin-3, CK19, HBME1, and Ret oncoprotein in the diagnosis of thyroid neoplasms by fine needle aspiration biopsy. Cytojournal 2009; :18.
Nikiforov Y, Ohori N, Hodak S, et al. Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab 2011; 96:3390.
Ferraz C, Eszlinger M, Paschke R. Current state and future perspective of molecular diagnosis of fineneedle aspiration biopsy of thyroid nodules. J Clin Endocrinol Metab 2011; 96:2016.
Shen R, Liyanarachchi S, Li W, et al. MicroRNA signature in thyroid fine needle aspiration cytology applied to “atypia of undetermined significance” cases. Thyroid 2012; 22:9.
Alexander E, Kennedy G, Baloch Z, et al. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med 2012; 367:705.
Cappola A, Mandel S. Molecular testing in thyroid cancer: BRAF mutation status and mortality. JAMA 2013;309:1529.
Derdas S, Soulitzis N, Balis V, et al. Expression analysis of B-Raf oncogene in V600E-negative benign and malignant tumors of the thyroid gland: correlation with late disease onset. Med Oncol 2013; 30:336.
Syrenicz A, Kozio?ek M, Ciechanowicz A, et al. New insights into the diagnosis of nodular goiter. Thyroid Research 2014, 7:6
Smith P, Salomone L, Hanks J. Thyroid. En TOWNSEND C, BEAUCHAMP R, EVERS R, et al. Sabiston Textbook of Surgery: the biological basis of modern surgical practice. 19th ed. Cap 38. Elsevier Saunders, Philadelphia 2012.
LAL G, CLARK O. Tiroides, paratiroides y suprarrenales. En Brunicardi C, Andersen D, Billiar T, et al.
Schwartz. Principios de Cirugía. 9º ed. Cap 38. McGraw-Hill Interamericana Editores, México 2010.
Maitra A. Sistema endocrino. En KUMAR V, ABBAS A, FAUSTO N, et al. Robbins y Cotran. Patología estructural y funcional. 8º ed. Cap 24. Elsevier España, Barcelona 2010.
Ikeda Y, Takami H, Sasaki Y, et al. Endoscopic neck surgery by the axillary approach. J A Coll Surg 2000;
:336.
Palazzo F, SebagF, Henry F. Endocrine surgical technique: endoscopic thyroidectomy via the lateral approach. Surg Endosc 2006; 20:339.
Miccoli P, Berti P, Frustaci G, et al. Video-assisted thyroidectomy: indications and results. Langenbecks Arch Surg 2006; 391:68.
Kang S, Lee S, Lee S, et al. Robotic thyroid surgery using a gasless, transaxillary approach and the da Vinci S system: the operative outcomes of 338 consecutive patients. Surgery 2009; 146:1048.
Kuppersmith R, Holsinger f. Robotic thyroid surgery: an initial experience with North American patients.Laryngoscope 2011; 121:521.
Venkat R, Guerrero M. Recent advances in the surgical treatment of differentiated thyroid cancer: a comprehensive review. Scientific World Journal. 2013; 2013:425136.103
Morrison A, Suh H, Hodin A. The surgical management of thyroid cancer. Rambam Maimonides Med J. 2014Apr 28; 5(2):e0008.
Haymart MR, Banerjee M, Yang D, et al. Variation in the management of thyroid cancer. J Clin Endocrinol Metab 2013; 98:2001.
Papaleontiou M, Haymart M. New insights in risk stratification of differentiated thyroid cancer Curr Opin Oncol 2014; 26:1.
Tuttle R, Tala H, Shah J, et al. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. Thyroid 2010; 20:1341.
Pitoia F, Bueno F, Urcluoli C, et al. Outcome of patients with differentiated thyroid cancer risk stratified
according to the American Thyroid Association and Latin-American Thyroid Society risk of recurrence classification systems. Thyroid 2013; 23:1401.
Nixon IJ, Ganly I, Patel SG, et al. The results of selective use of radioactive iodine on survival and on recurrence in the management of papillary thyroid cancer, based on Memorial Sloan-Kettering Cancer Center risk group stratification. Thyroid 2013; 23:683.
Gharib H, Hegedüs L, Pacella C, et al. Clinical review: Nonsurgical, image-guided, minimally invasive therapy for thyroid nodules. J Clin Endocrinol Metab 2013; 98:3949.
Jong J, Kang S, Yun J, et al. Comparative study of endoscopic thyroidectomy versus conventional open thyroidectomy in papillary thyroid microcarcinoma (PTMC) patients. J Surg Oncol 2009; 100:477.
Di J, Zhang H, Han X, et al. Minimally invasive video-assisted thyroidectomy for accidental papillary thyroid microcarcinoma: comparison with conventional open thyroidectomy with 5 years follow-up. Chin Med 2011; 124;3293.
Kim W, Kim J, Hur S, et al. Is robotic surgery superior to endoscopic and open surgeries in thyroid cancer? World J Surg 2011; 35:779.
Lee J, Lee J, Nah K, et al. Comparison of endoscopic and robotic thyroidectomy. Ann Surg Oncol 2011; 18: 1439.
Chung Y, Choe J, Kang K, et al. Endoscopic thyroidectomy for thyroid malignancies: comparison with conventional open thyroidectomy. World J Surg 2007; 31:2302.
Glover R, Gundara S, Norlén O, et al. The pros and cons of prophylactic central neck dissection in papillary thyroid carcinoma. Gland Surg 2013; 2:196.
Chan A, Lang B, Wong K. The pros and cons of routine central compartment neck dissection for clinically nodal negative (cN0) papillary thyroid cancer. Gland Surg 2013; 2:186.
Kendall-Taylor P. The UK Evidence-Based guidelines for the management of thyroid cancer: key recommendations. En Mazzaferri E, Harmer C, Mallick U, et al. Practical management of thyroid cancer. Cap 2. Springer-Verlag, London 2006.
Mallick U. Thyroid cancer multidisciplinary team and the organisational paradigm. En Mazzaferri E, Harmer C, Mallick U, et al. Practical management of thyroid cancer. Cap 3. Springer-Verlag, London 2006.
Carty S, Doherty G, Inabnet III W, et al. American Thyroid Association Statement on the essential elements of interdisciplinary communication of perioperative information for patients undergoing thyroid cancer surgery. Thyroid 2012; 22:395.
Rosenthal M. Ethical issues in the management of thyroid disease. Endocrinol Metab Clin North Am 2014; 43:545.
Rodríguez H. Seudoconsentimiento informado en Uruguay. Rev Med Urug 2002; 18:89.
González D, Rodríguez H, Berro G. Consentimiento informado. Análisis crítico de su aplicación en un servicio quirúrgico. Rev Med Uruguay 2005; 21:291.
PERINETTI H, VIA E. Complicaciones en la cirugía tiroidea: nervio recurrente y glándula paratirodea. Rev Arg Cir 1988; 54:69.
CASTRO M, GHARIB H. Thyroid diseasse. En Camacho P, Gharib H, Sizemore G. Evidence-based endocrinology. 3ºrd. Cap 2. Lippincott William & Wilkins. Philadelphia 2012.
Führer D, Bockisch A, Schmid KW. Euthyroid goiter with and without nodules—diagnosis and treatment. Dtsch Arztebl Int 2012; 109:506.
PERROS P. Thyroid nodules. En: MAZZAFERRI E, HARMER C, MALLICK U, et al. Practical Management of Thyroid Cancer. Cap 7. Springer-Verlag, London 2006.
Suzuki S, Fukunari N, Kameyama K, et al. How is the natural history of nodules diagnosed as benign (growth and re duction rates)? En Takami H, Ito Y, Noguchi H, et al. Treatment of thyroid tumor. Cap 10. Springer Japan, Tokyo 2013.
Alexander E, Hurwitz S, Heering J, et al. Natural history of benign solid and cystic thyroid nodules. Ann
Intern Med 2003; 138:315.
Kuma K, Matsuzuka F, Kobayashi A, et al. Outcome of long standing solitary thyroid nodules. World J Sur 1992; 16:583.
Suzuki S, Fukunari N, Kameyama K, et al. Does TSH suppression therapy reduce the size of tumors diagnosed as benign? En Takami H, Ito Y, Noguchi H, et al. Treatment of thyroid tumor. Cap 11. Springer
Japan, Tokyo 2013.
YOUSEF A, CLARK J, DOI S. Thyroxine suppression therapy for benign, non-functioning solitary thyroid nodules: a quality-effects meta-analysis. Clin Med Res. 2010; 8:150.
BANDEIRA-ECHTLER E, BERGERHOFF K, RICHTER B. Levothyroxine or minimally invasive therapies for benign thyroid nodules. Cochrane Database Syst Rev. 2014; 6:CD004098.
BONNEMA S, HEGEDÜS L. Radioiodine therapy in benign thyroid diseases: effects, side effects, and factors affecting therapeutic outcome. Endocr Rev 2012; 33:920.
BAHN R, BURCH H, COOPER D, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract 2011; 17:456.
NYGAARD B, HEGEDÜS L, NIELSEN K, et al. Longterm effect of radioactive iodine on thyroid function and size in patients with solitary autonomously functioning toxic thyroid nodules. Clin Endocrinol 1999; 50:197. 105
VILLADSEN MJ, SØRENSEN CH, GODBALLE C, et al. Need for thyroidectomy in patients treated with radioactive iodide for benign thyroid disease. Dan Med Bull. 2011; 58:A4343.
LEE S, AHN I. Effectiveness of percutaneous ethanol injection therapy in benign nodular and cystic thyroid diseases: long-term follow-up experience. Endocr J 2005; 52:455.
SUZUKI S, FUKUNARI N, K AMEYAMA K, et al. What is the efficacy of percutaneous ethanol injection therapy for autonomously functioning thyroid nodules? En Takami H, Ito Y, Noguchi H, et al. Treatment of thyroid tumor. Cap 13. Springer Japan, Tokyo 2013.
SUZUKI S, FUKUNARI N, KAMEYAMA K, et al. Do cystic nodules decrease in volume by aspiration and drainage of content fluid and percutaneous ethanol injection therapy? En Takami H, Ito Y, Noguchi H, et al.
Treatment of thyroid tumor. Cap 14. Springer Japan, Tokyo 2013.
VALCAVI R, FRASOLDATI A. Ultrasound-guided percutaneous ethanol injection therapy in thyroid cystic nodules. Endocr Pract 2004; 10:269.
BENNEDBAEK FN, HEGEDÜS L. Treatment of recurrent thyroid cysts with ethanol: a randomized double-blind controlled trial. J Clin Endocrinol Metab 2003; 88:5773.
HA E, BAEK J, LEE J. The efficacy and complications of radiofrequency ablation of thyroid nodules. Curr Opin Endocrinol Diabetes Obes 2011; 18:310.
WONG K, LANG B. Use of radiofrequency ablation in benign thyroid nodules:a literature review and updates. Int J Endocrinol 2013; 2013:428363.
BAEK J, LEE J, SUNG J, et al. Complications encountered in the treatment of benign thyroid nodules with USguided radiofrequency ablation: a multicenter study. Radiology 2012; 262:335.
SUNG J, BAEK J, KIM K, et al. Single-session treatment of benign cystic thyroid nodules with ethanol versus radiofrequency ablation: a prospective randomized study. Radiology 2013; 269:293.
PAPINI E, RAGO T, GAMBELUNGHE G, et al. Long-term efficacy of ultrasound-guided laser ablation for benign solid thyroid nodules. results of a three-year multicenter prospective randomized trial. J Clin Endocrinol Metab 2014 Jul 22:jc20141826.
PAPINI E, BIZZARRI G, PACELLA C, et al. Percutaneous laser ablation of benign and malignant thyroid nodules. Curr Opin Endocrinol Diabetes Obes. 2008; 15:434.
SHIN J, BAEK J, HA E, et al. Radiofrequency ablation of thyroid nodules: basic principles and clinical application. Int J Endocrinol. 2012; 2012:919650. doi: 10.1155/2012/919650.
GUENETTE J, MONCHIK J, DUPUY D. Image-guided ablation of postsurgical locoregional recurrence of biopsyproven well-differentiated thyroid carcinoma. J Vasc Interv Radiol 2013; 24:672.
BAEK J, KIM Y, SUNG J, et al. Locoregional control of metastatic well-differentiated thyroid cancer by ultrasound-guided radiofrequency ablation. AJR Am J Roentgenol 2011; 197:W331.
MCKEE S, WU H, WANG X, et al. Hürthle cell neoplasms diagnosed by fine needle aspiration are not associated with an increased risk of malignancy. Acta Cytol 2014; 58:235.
PU R, YANG J, WASSERMAN P, et al. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration? Diagn Cytopathol 2006; 34:330.106
CONZO G, CALÒ P, GAMBARDELLA C, et al. Controversies in the surgical management of thyroid follicular neoplasms. Retrospective analysis of 721 patients. Int J Surg 2014; 12S1:S29.
CALÒ P, MEDAS F, SANTA CRUZ R, et al. Follicular nodules (Thy3) of the thyroid: is total thyroidectomy the best option? BMC Surg 2014; 14:12.
KAHMKE R, LEE W, PUSCAS L, et al. Utility of intraoperative frozen sections during thyroid surgery. Int J Otolaryngol 2013; 2013:496138.
ANTIC T, TAXY J. Thyroid frozen section: supplementary or unnecessary? Am J Surg Pathol. 2013; 37:282.
CETIN B, ASLAN S, HATIBOGLU C, et al. Frozen section in thyroid surgery: is it a necessity? Can J Surg 2004; 47:29.
LIU F, LIOU M, HSUEH C, et al. Thyroid follicular neoplasm: analysis by fine needle aspiration cytology, frozen section, and histopathology. Diagn Cytopathol 2010; 38:801.
LIVOLSI VA1 , BALOCH ZW. Use and abuse of frozen section in the diagnosis of follicular thyroid lesions. Endocr Pathol 2005; 16:285.
BASOLO F, UGOLINI C, PROIETTI A, et al. Role of frozen section associated with intraoperative cytology in comparison to FNA and FS alone in the management of thyroid nodules. Eur J Surg Oncol 2007; 33:769.
CIMARRA L y col. Cáncer de tiroides en general. Carcinomas diferenciados: carcinoma papilar y carcinoma folicular. En: Diagnóstico y tratamiento de las enfermedades quirúrgicas de la glándula tiroides. Cap 5. Oficina del Libro FEFMUR, Montevideo 2006.
MAZZAFERRI E. An overview of the management of thyroid cancer En: MAZZAFERRI E, HARMER C, MALLICK U, et al. Practical management of thyroid cancer. Cap 1. Springer-Verlag, London 2006.
VILLARET D, MAZZAFERRI E. Initial thyroid surgery for patient with differentiated thyroid carcinoma. En: MAZZAFERRI E, HARMER C, MALLICK U, et al. Practical management of thyroid cancer. Cap 12. Springer-Verlag, London 2006.
BILIMORIA K, BENTREM D, KO C, et al. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 2007; 246:375.
Thyroid. En: EDGE S, BYRD D, COMPTON C, et al. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer, 2010, 87.
NIXON I, SHAHA A, PATEL S, et al. Surgical diagnosis. Frozen section and the extent of surgery. Otolaryngol Clin N Am 2014, 47:519.
LUSTER M, WEBER T, VERBURG F. Differentiated thyroid cancer-personalized therapies to prevent overtreatment. Nat Rev Endocrinol 2014; 10:563.
KAMMORI M, FUKUMORI T, SUGISHITA Y, et al. Therapeutic strategy for low-risk thyroid cancer in Kanaji Thyroid Hospital Endocr J 2014; 61:1.
TAKAMI H, ITO Y, OKAMOTO T, et al. Revisiting the guidelines issued by the Japanese Society of Thyroid Surgeons and Japan Association of Endocrine Surgeons: a gradual move towards consensus between Japanese and western practice in the management of thyroid carcinoma. World J Surg 2014; 38:2002.
IMAI T, KITANO H, SUGITANI I, et al. When can papillary microcarcinoma (papillary carcinoma measuring 1 cm or less) be observed without immediate surgery? En Takami H, Ito Y, Noguchi H, et al. Treatment of thyroid tumor. Cap 20. Springer Japan, Tokyo 2013.
ITO Y, MIYAUCHI A, KIHARA M, et al. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid 2014; 24:27.
PAPINI E, GUGLIELMI R, GHARIB H, et al. Ultrasound-guided laser ablation of incidental papillary thyroid microcarcinoma: a potential therapeutic approach in patients at surgical risk. Thyroid 2011; 21:917.
NA D, LEE J, JUNG S, et al. Radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: consensus statement and recommendations. Korean J Radiol 2012; 13:117.
PACELLA C, PAPINI E. Image-guided percutaneous ablation therapies for local recurrences of thyroid tumors. J Endocrinol Invest 2013; 36:61.
PAPINI E, BIZZARRI G, BIANCHINI A, et al. Percutaneous ultrasound-guided laser ablation is effective for treating selected nodal metastases in papillary thyroid cancer. J Clin Endocrinol Metab 2013; 98:E92.
CARON N, STURGEON C, CLARK O. The specialist endocrine surgeon. En: MAZZAFERRI E, HARMER C, MALLICK U, et al. Practical management of thyroid cancer. Cap 11. Springer-Verlag, London 2006.
CIMARRA L y col. Tiroidectomía y vaciamientos ganglionares, Táctica y técnica quirúrgica. En: Diagnóstico y tratamiento de las enfermedades quirúrgicas de la glándula tiroides. Cap 5. Oficina del Libro FEFMUR, Montevideo 2006.
PARDAL J, CUELLO J, SANTIAGO L. Development of a checklist in risk management in thyroidectomy. Endocrinol Nutr 2014; pii: S1575-0922(14)00139-9.
TERRIS D, SNYDER S, CARNEIRO-PLA D, et al. American Thyroid Association statement on outpatient thyroidectomy. Thyroid 2013; 23:1193.
SÁNCHEZ J, RECIO G, GUEROLA A, et al. Tiroidectomía en régimen de cirugía mayor ambulatoria. Estudio prospectivo. Cir Esp 2006; 80:206.
DORAN H, ENGLAND J, PALAZZO F. Questionable safety of thyroid surgery with same day discharge. Ann R Coll Surg Engl 2012; 94:543.
ELISHA S, BOYTIM M, BORDI S, et al. Anesthesia case management for thyroidectomy. AANA J 2010; 78:151.
LENNARD T. Complications of thyroid surgery. En: MAZZAFERRI E, HARMER C, MALLICK U, et al. Practical management of thyroid cancer. Cap 14. Springer-Verlag, London 2006.
DUKE W, CHAUNG K, TERRIS D. Contemporary surgical techniques. Otolaryngol Clin N Am 2014; 47:529.
PHITAYAKORN R. Minimally invasive thyroidectomy for thyroid carcinoma En: LINOS D, CHUNG W. Minimally invasive thyroidectomy. Cap 22. Springer-Verlag Berlin 2012.
MICCOLI P, MATERAZZI G. Minimally invasive video-assisted thyroidectomy. En: LINOS D, CHUNG W. Minimally invasive thyroidectomy. Cap 9. Springer-Verlag Berlin 2012.
LINOS D. Minimally invasive non-endoscopic thyroidectomy: The MINET approach. En: LINOS D, CHUNG W. Minimally invasive thyroidectomy. Cap 11. Springer-Verlag Berlin 2012. 108
ALESINA P, ROLFS T, RUHLAND K, et al. Evaluation of postoperative pain after minimally invasive video-assisted and conventional thyroid ectomy: results of a prospective study. ESES Vienna presentation. Langenbecks Arch Surg 2010; 395:845.
MICCOLI P, MINUTO M, UGOLINI C, et al. Minimally invasive video-assisted thyroidectomy for benign thyroid disease: an evidence-based review. World J Surg 2008; 32:1333.
SGOURAKIS G, SOTIROPOULOS G, NEUHAUSER M, et al. Comparison between minimally invasive video-assisted thyroidectomy and conventional thyroidectomy: is there any evidence-based information? Thyroid 2008; 18:721.
GROGAN R, DUH Q. Conventional thyroidectomy versus MIT: An Outcome Analysis. En: LINOS D, CHUNG W.
Minimally invasive thyroidectomy. Cap 23. Springer-Verlag Berlin 2012.
MICCOLI P, PINCHERA A, MATERAZZI G, et al. Surgical treatment of low- and intermediate-risk papillary thyroid cancer with minimally invasive video-assisted thyroidectomy. J Clin Endocrinol Metab 2009; 94:1618.
ECONOMOPOULOS K, LINOS D. Endoscopic thyroidectomy in the neck. En: LINOS D, CHUNG W. Minimally invasive thyroidectomy. Cap 9. Springer-Verlag Berlin 2012.
CHEN D, DING K, GUO K, et al. Gasless single incision endoscopic thyroidectomy. JSLS 2012; 16:60.
WRIGHT S. Endoscopic transaxillary thyroidectomy. En: LINOS D, CHUNG W. Minimally invasive thyroidectomy. Cap 12. Springer-Verlag Berlin 2012.
LINOS D. Endoscopic thyroidectomy using the gasless transaxillary approach. En: LINOS D, CHUNG W. Minimally invasive thyroidectomy. Cap 13. Springer-Verlag Berlin 2012.
KANG S, JEONG J, YUN J, et al. Gasless endoscopic thyroidectomy using trans-axillary approach; surgical outcome of 581 patients. Endocr J 2009; 56:361.
SOONMIN D, DUGAL N. Complications of minimally invasive thyroidectomy. En: LINOS D, CHUNG W. Minimally invasive thyroidectomy. Cap 22. Springer-Verlag Berlin 2012.
RABINOVICS N, FEINMESSER R, AIDAN P, et al. Robot-assisted transaxillary thyroid surgery-feasibility and safety of a novel technique. Rambam Maimonides Med J 2014; 5:e0013.
CHUNG W. Robotic gasless transaxillary thyroidectomy. En: LINOS D, CHUNG W. Minimally invasive thyroidectomy. Cap 14. Springer-Verlag Berlin 2012.
LANG B, WONG C, TSANG J, et al. A systematic review and meta-comparing surgically-related complications between robotic-assisted thyroidectomy and conventional open thyroidectomy. Ann Surg Oncol 2014; 21:850.
JACKSON N, YAO L, TUFANO R, et al. Safety of robotic thyroidectomy approaches: meta-analysis and systematic review. Head Neck 2014; 36:137.
LEE J, KANG S, JUNG J, et al. Multicenter study of robotic thyroidectomy: short-term postoperative outcomes and surgeon ergonomic considerations. Ann Surg Oncol 2011; 18:2538.
SANCHO J, SITGES-SERRA A. Técnica y complicaciones de la tiroidectomía y de la paratiroidectomía. En: PARRILLA P, LANDA J. Cirugía AEC. Cap 84. Editorial Médica Panamericana Madrid 2010.
PÉREZ J, VENTURELLI F. Complicaciones de la cirugía tiroidea. Cuad Cir 2007; 21:84.
VARALDO E, ANSALDO G, MASCHERINI M, et al. Neurological complications in thyroid surgery: a surgical point of view on laryngeal nerves. Front Endocrinol 2014; 5:108.109
CALÒ P, PISANO G, MEDAS F, et al. Identification alone versus intraoperative neuromonitoring of the recurrent laryngeal nerve during thyroid surgery: experience of 2034 consecutive patients. J Otolaryngol Head Neck Surg 2014; 43:16.
PISANU A, PORCEDDU G, PODDA M, et al. Systematic review with meta-analysis of studies comparing intraoperative neuromonitoring of recurrent laryngeal nerves versus visualization alone during thyroidectomy. J Surg Res 2014; 188:152.
HAYWARD N, GRODSKI S, YEUNG M, et al. Recurrent laryngeal nerve injury in thyroid surgery: a review. ANZ J Surg 2013; 83:15.
TESTINI M, NACCHIERO M, PICCINNI G, et al. Total thyroidectomy is improved by loupe magnification. Microsurgery 2004; 24:39.
DÍEZ M, SÁNCHEZ J, SÁNCHEZ-SECO M, et al. Determinación de paratirina en suero como factor predictivo de hipocalcemia tras tiroidectomía total. Cir Esp 2009; 85:96.
LANG B, YIH P, NG K. A prospective evaluation of quick intraoperative parathyroid hormone assay at the time of skin closure in predicting clinically relevant hypocalcemia after thyroidectomy. World J Surg 2012; 36:1300.
ITO Y, MIYAUCHI A, KOBAYASHI K, et al. Static and dynamic prognostic factors of papillary thyroid carcinoma [Review]. Endocr J 2014; doi: 10.1507/endocrj. EJ14-0303.
ITO Y, MIYAUCHI A, KIHARA M, et al. Prognostic values of clinical lymph node metastasis and macroscopic extrathyroid extension in papillary thyroid carcinoma [Review]. Endocr J 2014; 61:745.
VAISMAN F, MOMESSO D, BULZICO D, et al. Thyroid lobectomy is associated with excellent clinical outcomes in properly selected differentiated thyroid cancer patients with primary tumors greater than 1 cm. J Thyroid Res 2013; 2013:398194.
COSTA A, HERRERO A, FRESNO M, et al. BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma. Clin Endocrinol 2008; 68:618.
SUGINO K, KAMEYAMA K, NAGAHAMA M, et al. Does completion thyroidectomy improve the outcome of patients with minimally invasive follicular carcinoma of the thyroid? Ann Surg Oncol 2014; 21:2981.
PHITAYAKORN R, MCHENRY CR. Follicular and Hurthle cell carcinoma of the thyroid gland. Surg Oncol Clin N Am 2006; 15:603.
STACK B, FERRIS R, GOLDENBERG D, et al. American Thyroid Association consensus review and statement regarding the anatomy, terminology, and rationale for lateral neck dissection in differentiated thyroid cancer. Thyroid 2012; 22:501.
CARTY SE, COOPER DS, DOHERTY GM, et al. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid. 2009; 19:1153.
GIUGLIANO G, PROH M, GIBELLI B, et al. Central neck dissection in differentiated thyroid cancer: technical notes. Acta Otorhinolaryngol Ital 2014; 34:9.
RAFFAELLI M, DE CREA C, SESSA L, et al. Can intraoperative frozen section influence the extension of central neck dissection in cN0 papillary thyroid carcinoma? Langenbecks Arch Surg 2013; 398:383. 110
RAIJMAKERS P, PAUL M, LIPS P. Sentinel node detection in patients with thyroid carcinoma: a meta-analysis. World J Surg 2008; 32:1961.
JOZAGHI Y, RICHARDSON K, ANAND S, et al. Frozen section analysis and sentinel lymph node biopsy in well differentiated thyroid cancer. J Otolaryngol Head Neck Surg 2013; 42:48.
WATKINSON J. Management of cervical lymph nodes in differentiated thyroid cancer. En: MAZZAFERRI E, HARMER C, MALLICK U, et al. Practical management of thyroid cancer. Cap 13. Springer-Verlag, London 2006.
SCHOPPY D, HOLSINGER F. Management of the Neck in Thyroid Cancer. Otolaryngol Clin N Am 2014; 47:545.
WANG L, VERSNICK M, GILL A, et al. Level VII is an important component of central neck dissection for papillary thyroid cancer. Ann Surg Oncol 2013; 20:2261.
McHENRY C, STULBERG J. Prophylactic Central Compartment Neck Dissection for Papillary Thyroid Cancer. Surg Clin N Am 94 (2014) 529–
WANG T, CHEUNG K, FARROKHYAR F, et al. A Meta-analysis of the effect of prophylactic central compartment neck dissection on locoregional recurrence rates in patients with papillary thyroid cancer. Ann Surg Oncol 2013; 20:3477.
GIORDANO D, VALCAVI R, THOMPSON GB, et al. Complications of central neck dissection in patients with papillary thyroid carcinoma: results of a study on 1087 patients and review of the literature. Thyroid 2012;22:911.
HENRY J, GRAMATICA L, DENIZOT A, et al. Morbidity of prophylactic lymph node dissection in the central neck area in patients with papillary thyroid carcinoma. Langenbecks Arch Surg. 1998; 383:167.
PARK J, ROH J, LEE J, et al. Risk factors for central neck lymph node metastasis of clinically noninvasive, nodenegative papillary thyroid microcarcinoma. Am J Surg. 2014; 208:412.
SANCHO J, LENNARD T, PAUNOVIC I, et al. Prophylactic central neck disection in papillary thyroid cancer: a consensus report of the European Society of Endocrine Surgeons (ESES) Langenbecks Arch Surg 2014; 399:155.
MOO T, UMUNNA B, KATO M, et al. Ipsilateral versus bilateral central neck lymph node dissection in papillary thyroid carcinoma. Ann Surg 2009; 250:403.
RAFFAELLI M, DE CREA C, SESSA L, et al. Prospective evaluation of total thyroidectomy versus ipsilateral versus bilateral central neck dissection in patients with clinically node-negative papillary thyroid carcinoma. Surgery 2012; 152:957.
LEE J, KOO B. The prognostic implication and potential role of BRAF mutation in the decision to perform elective neck dissection for thyroid cancer. Gland Surgery 2013; 2:206.
TANG C, YANG L, WANG N, et al. High expression of GPER1, EGFR and CXCR1 is associated with lymph node metastasis in papillary thyroid carcinoma. Int J Clin Exp Pathol 2014; 7:3213.
IMAI T, KITANO H, SUGITANI I, et al. Does dissection of the lateral compartment improve the prognosis of papillary carcinoma patients? En Takami H, Ito Y, Noguchi H, et al. Treatment of thyroid tumor. Cap 19. Springer Japan, Tokyo 2013.
